COVID-19 Vaccines: EUA Route Offers Advantage In Review Speed, Not Level Of Evidence

 
• By Sue Sutter

US FDA’s ‘may be effective’ standard for granting an emergency use authorization is expected to be comparable to the substantial evidence of effectiveness needed to support full licensure of a COVID-19 vaccine, although EUA allows for a more rapid review, agency officials say.

UNINCORPORATED DEKALB COUNTY, GA -Â?Â? MARCH 30: The US Centers for Disease Control and Prevention headquarters on March 30, 2013. The CDC is the national public health institute of the United States.
A CDC advisory committee heard about the level of evidence needed for an emergency use authorization. • Source: Shutterstock

More from Vaccines

More from Pink Sheet